A quick paster type of soluble nanoparticle microneedle patch for the treatment of obesity

Songyue Chen,Junbo Wang,Liyu Sun,Fangzhi Xia,Wenzhe Li,Lan Yuan,Chang Liu,Peishan Li,Chunjie Bao,Mengjie Wang,Guiling Wang,Jianwei Li,Ying Xie,Wanliang Lu

DOI: https://doi.org/10.1016/j.biomaterials.2024.122687

IF: 14

Biomaterials

Abstract:Obesity is a major public burden on the working population and induces chronic diseases. Its treatment often requires long-term medication, which makes patient compliance difficult. In this study, we reported the value of HORN-MN, which comprised a fast-soluble hyaluronic acid microneedle matrix and a weak acid-degradable oleanolic acid dimer of rosiglitazone nanoparticles. The results showed that the microneedles easily punctured the stratum corneum and dissolved in the dermis of the abdominal wall within 5 min, followed by the release of rosiglitazone nanoparticles. Thereafter, the nanoparticles were endocytosed by macrophages and white adipocytes, then degraded to oleanolic acid in the lysosomes, thereby, releasing rosiglitazone. Oleanolic acid significantly improved the inflammatory status of obese adipose tissue and promoted white adipocyte browning, and rosiglitazone significantly potentiated WAC browning. Accordingly, the patch demonstrated a remarkable obesity-reducing efficacy in mice. In conclusion, this study developed a quick paster type of soluble rosiglitazone nanoparticle microneedle for the treatment of obesity. This patch can be suitable for working people, with an evident obesity-reducing efficacy but no effect on skin integrity despite multiple administrations.